ResearchMoz

Global Markets Direct Market Research Reports

Global Markets Direct is a leading provider of global business intelligence and market analysis. The company publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. With a large dedicated research and analysis capability, Global Markets Direct employs rigorous primary and secondary research techniques in developing unique data sets and research materials.

At the heart of Global Markets Direct are unique databases, updated live, covering millions of rows of key information for the studied industry at a global level.

List of reports from Global Markets Direct

Displaying 1 to 30 (of 5578 records)
Contact Dermatitis - Pipeline Review, H2 2014
Oct 2014  
Contact Dermatitis - Pipeline Review, H2 2014 Summary Global Markets Directs, Contact Dermatitis - Pipeline Review, H2 2014, provides an overview of the Contact Dermatitiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Contact Dermatitis, complete with comparative analysis at various stages, therapeutics assessment by drug target,...
$2000
Enterocolitis - Pipeline Review, H2 2014
Oct 2014  
Enterocolitis - Pipeline Review, H2 2014 Summary Global Markets Directs, Enterocolitis - Pipeline Review, H2 2014, provides an overview of the Enterocolitiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Enterocolitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action...
$2000
Hepatic Encephalopathy - Pipeline Review, H2 2014
Oct 2014  
Hepatic Encephalopathy - Pipeline Review, H2 2014 Summary Global Markets Directs, Hepatic Encephalopathy - Pipeline Review, H2 2014, provides an overview of the Hepatic Encephalopathys therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hepatic Encephalopathy, complete with comparative analysis at various stages, therapeutics assessment by...
$2000
Alcoholic Hepatitis - Pipeline Review, H2 2014
Oct 2014  
Alcoholic Hepatitis - Pipeline Review, H2 2014 Summary Global Markets Directs, Alcoholic Hepatitis - Pipeline Review, H2 2014, provides an overview of the Alcoholic Hepatitiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Alcoholic Hepatitis, complete with comparative analysis at various stages, therapeutics assessment by drug target,...
$2000
Thrombotic Thrombocytopenic Purpura - Pipeline Review, H2 2014
Oct 2014  
Thrombotic Thrombocytopenic Purpura - Pipeline Review, H2 2014 Summary Global Markets Directs, Thrombotic Thrombocytopenic Purpura - Pipeline Review, H2 2014, provides an overview of the Thrombotic Thrombocytopenic Purpuras therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Thrombotic Thrombocytopenic Purpura, complete with comparative...
$2000
Corneal Graft Rejection - Pipeline Review, H2 2014
Oct 2014  
Corneal Graft Rejection - Pipeline Review, H2 2014 Summary Global Markets Directs, Corneal Graft Rejection - Pipeline Review, H2 2014, provides an overview of the Corneal Graft Rejections therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Corneal Graft Rejection, complete with comparative analysis at various stages, therapeutics assessment...
$2000
Gonorrhea - Pipeline Review, H2 2014
Oct 2014  
Gonorrhea - Pipeline Review, H2 2014 Summary Global Markets Directs, Gonorrhea - Pipeline Review, H2 2014, provides an overview of the Gonorrheas therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Gonorrhea, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of...
$2000
Toxoplasmosis - Pipeline Review, H2 2014
Oct 2014  
Toxoplasmosis - Pipeline Review, H2 2014 Summary Global Markets Directs, Toxoplasmosis - Pipeline Review, H2 2014, provides an overview of the Toxoplasmosiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Toxoplasmosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action...
$2000
Hand, Foot And Mouth Disease - Pipeline Review, H2 2014
Oct 2014  
Hand, Foot And Mouth Disease - Pipeline Review, H2 2014 Summary Global Markets Directs, Hand, Foot And Mouth Disease - Pipeline Review, H2 2014, provides an overview of the Hand, Foot And Mouth Diseases therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hand, Foot And Mouth Disease, complete with comparative analysis at various stages,...
$2000
Diabetic Peripheral Neuropathy - Pipeline Review, H2 2014
Oct 2014  
Diabetic Peripheral Neuropathy - Pipeline Review, H2 2014 Summary Global Markets Directs, Diabetic Peripheral Neuropathy - Pipeline Review, H2 2014, provides an overview of the Diabetic Peripheral Neuropathys therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Diabetic Peripheral Neuropathy, complete with comparative analysis at various...
$2000
Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2014
Oct 2014  
Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2014 Summary Global Markets Directs, Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2014, provides an overview of the Proliferative Diabetic Retinopathy (PDR)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Proliferative Diabetic Retinopathy (PDR), complete...
$2000
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2014
Oct 2014  
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2014 Summary Global Markets Directs, Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2014, provides an overview of the Mucopolysaccharidosis I (MPS I) (Hurler Syndrome)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Mucopolysaccharidosis I...
$2000
Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) - Pipeline Review, H2 2014
Oct 2014  
Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) - Pipeline Review, H2 2014 Summary Global Markets Directs, Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) - Pipeline Review, H2 2014, provides an overview of the Mucopolysaccharidosis II (MPS II) (Hunter Syndrome)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for...
$2000
Mycosis Fungoides - Pipeline Review, H2 2014
Oct 2014  
Mycosis Fungoides - Pipeline Review, H2 2014 Summary Global Markets Directs, Mycosis Fungoides - Pipeline Review, H2 2014, provides an overview of the Mycosis Fungoidess therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Mycosis Fungoides, complete with comparative analysis at various stages, therapeutics assessment by drug target,...
$2000
Chemotherapy Induced Myelosuppression - Pipeline Review, H2 2014
Oct 2014  
Chemotherapy Induced Myelosuppression - Pipeline Review, H2 2014 Summary Global Markets Directs, Chemotherapy Induced Myelosuppression - Pipeline Review, H2 2014, provides an overview of the Chemotherapy Induced Myelosuppressions therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Chemotherapy Induced Myelosuppression, complete with...
$2000
Papillary Thyroid Cancer - Pipeline Review, H2 2014
Oct 2014  
Papillary Thyroid Cancer - Pipeline Review, H2 2014 Summary Global Markets Directs, Papillary Thyroid Cancer - Pipeline Review, H2 2014, provides an overview of the Papillary Thyroid Cancers therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Papillary Thyroid Cancer, complete with comparative analysis at various stages, therapeutics...
$2000
Germ Cell Tumors - Pipeline Review, H2 2014
Oct 2014  
Germ Cell Tumors - Pipeline Review, H2 2014 Summary Global Markets Directs, Germ Cell Tumors - Pipeline Review, H2 2014, provides an overview of the Germ Cell Tumorss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Germ Cell Tumors, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism...
$2000
Hormone-Sensitive Prostate Cancer - Pipeline Review, H2 2014
Oct 2014  
Hormone-Sensitive Prostate Cancer - Pipeline Review, H2 2014 Summary Global Markets Directs, Hormone-Sensitive Prostate Cancer - Pipeline Review, H2 2014, provides an overview of the Hormone-Sensitive Prostate Cancers therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hormone-Sensitive Prostate Cancer, complete with comparative analysis at...
$2000
Retinoblastoma - Pipeline Review, H2 2014
Oct 2014  
Retinoblastoma - Pipeline Review, H2 2014 Summary Global Markets Directs, Retinoblastoma - Pipeline Review, H2 2014, provides an overview of the Retinoblastomas therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Retinoblastoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action...
$2000
Leiomyosarcoma - Pipeline Review, H2 2014
Oct 2014  
Leiomyosarcoma - Pipeline Review, H2 2014 Summary Global Markets Directs, Leiomyosarcoma - Pipeline Review, H2 2014, provides an overview of the Leiomyosarcomas therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Leiomyosarcoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action...
$2000
Metastatic Uveal Melanoma - Pipeline Review, H2 2014
Oct 2014  
Metastatic Uveal Melanoma - Pipeline Review, H2 2014 Summary Global Markets Directs, Metastatic Uveal Melanoma - Pipeline Review, H2 2014, provides an overview of the Metastatic Uveal Melanomas therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Metastatic Uveal Melanoma, complete with comparative analysis at various stages, therapeutics...
$2000
Retinopathy Of Prematurity - Pipeline Review, H2 2014
Oct 2014  
Retinopathy Of Prematurity - Pipeline Review, H2 2014 Summary Global Markets Directs, Retinopathy Of Prematurity - Pipeline Review, H2 2014, provides an overview of the Retinopathy Of Prematuritys therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Retinopathy Of Prematurity, complete with comparative analysis at various stages,...
$2000
Nerve Gas & Pestiside Poisioning - Pipeline Review, H2 2014
Oct 2014  
Nerve Gas & Pestiside Poisioning - Pipeline Review, H2 2014 Summary Global Markets Directs, Nerve Gas & Pestiside Poisioning - Pipeline Review, H2 2014, provides an overview of the Nerve Gas & Pestiside Poisionings therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Nerve Gas & Pestiside Poisioning, complete with comparative analysis at...
$2000
Premature Labor (Tocolysis) - Pipeline Review, H2 2014
Oct 2014  
Premature Labor (Tocolysis) - Pipeline Review, H2 2014 Summary Global Markets Directs, Premature Labor (Tocolysis) - Pipeline Review, H2 2014, provides an overview of the Premature Labor (Tocolysis)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Premature Labor (Tocolysis), complete with comparative analysis at various stages,...
$2000
Molecular Partners AG - Product Pipeline Review - 2014
Oct 2014  
Molecular Partners AG - Product Pipeline Review - 2014 Summary Global Markets Directs, Molecular Partners AG - Product Pipeline Review - 2014, provides an overview of the Molecular Partners AGs pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Molecular Partners AGs, complete with comparative...
$1500
Kuhnil Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014
Oct 2014  
Kuhnil Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014 Summary Global Markets Directs, Kuhnil Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014, provides an overview of the Kuhnil Pharmaceutical Co., Ltd.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Kuhnil Pharmaceutical...
$1500
Colby Pharmaceutical Company - Product Pipeline Review - 2014
Oct 2014  
Colby Pharmaceutical Company - Product Pipeline Review - 2014 Summary Global Markets Directs, Colby Pharmaceutical Company - Product Pipeline Review - 2014, provides an overview of the Colby Pharmaceutical Companys pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Colby Pharmaceutical Companys,...
$1500
Sigmoid Pharma Limited - Product Pipeline Review - 2014
Oct 2014  
Sigmoid Pharma Limited - Product Pipeline Review - 2014 Summary Global Markets Directs, Sigmoid Pharma Limited - Product Pipeline Review - 2014, provides an overview of the Sigmoid Pharma Limiteds pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Sigmoid Pharma Limiteds, complete with comparative...
$1500
Prosensa Therapeutics B.V. - Product Pipeline Review - 2014
Oct 2014  
Prosensa Therapeutics B.V. - Product Pipeline Review - 2014 Summary Global Markets Directs, Prosensa Therapeutics B.V. - Product Pipeline Review - 2014, provides an overview of the Prosensa Therapeutics B.V.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Prosensa Therapeutics B.V.s, complete...
$1500
CIMAB S.A. - Product Pipeline Review - 2014
Oct 2014  
CIMAB S.A. - Product Pipeline Review - 2014 Summary Global Markets Directs, CIMAB S.A. - Product Pipeline Review - 2014, provides an overview of the CIMAB S.A.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of CIMAB S.A.s, complete with comparative analysis at various stages, therapeutics...
$1500
 
Displaying 1 to 30 (of 5578 records)

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com

Popular Publishers

Transparency Market Research
ICD Research
Technavio
 
GBI Research
Winter Green Research
GlobalData